* NextGen Healthcare Inc NXGN.OQ NXGN.O is expected
to show a
rise in quarterly revenue when it reports results
* The Irvine California-based company is expected to report
a
11.0% increase in revenue to $176.954 million from $159.44
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for NextGen Healthcare
Inc is
for earnings of 25 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 7
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for NextGen
Healthcare Inc is $23.95, above its last closing price
of $23.84.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 0.22 0.22 0.24 Beat 9.1
Mar. 31 2023 0.28 0.29 0.31 Beat 8.3
Dec. 31 2022 0.27 0.27 0.26 Missed -4.3
Sep. 30 2022 0.23 0.23 0.25 Beat 9.5
Jun. 0.16 0.16 0.16 Met 2.6
30 2022
Mar. 31 2022 0.19 0.19 0.19 Met -2.2
Dec. 31 2021 0.20 0.21 0.24 Beat 15.2
Sep. 30 2021 0.24 0.23 0.29 Beat 26.1
This summary was machine generated October 20 at 11:44 GMT. All
figures in US dollars unless otherwise stated